Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: Long-term results in 30 patients
Cervantes FJ, Alvarez-Larran A, Domingo A et al. 2005. Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients. British Journal of Haematology 129:771-775.
Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy
Herbar M, Kaplan C, Caulier MT et al. 1996. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy. British Journal of Haematology 94:112-115.
Antithymocyte globulin and cyclosporine for severe aplastic anemia: Association between hematologic response and long-term outcome
Rosenfeld S, Follmann D, Nunez O et al. 2003. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. Journal of the American Medical Association 289:1130-1135.
Prevention of refractoriness and HLA-alloimmunization using filtered blood products
Sniecinski I, O'Donnell MR, Nowicki B et al. 1988. Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 71:1402-1407.
